An experiment was conducted to evaluate the effects of Bacillus coagulans ATCC 7050 (B. coagulans) on the performance, intestinal morphology and microflora of broiler chickens. Six-hundred 1-day-old broilers were randomly assigned into five treatment groups with four replicates for 42 days. There were five dietary treatments: negative control, positive control (antibiotics, 200 mg/kg zinc–bacitracin), 0.10, 0.20 and 0.25 g/kg B. coagulans. Dietary B. coagulans improved feed conversion ratio throughout the entire experimental period compared with the negative control (P = 0.02). Dietary B. coagulans significantly increased the number of lactobacilli (P = 0.01) and tended to decrease coliform bacteria (P = 0.06) in the duodenum. Dietary B. coagulans tended to increase villous height (P = 0.08) but had no effect on crypt depth in the jejunum. There were no significant differences (P > 0.05) in serum cholesterol, triglyceride, high density lipoprotein cholesterol and low density lipoprotein cholesterol between groups. In conclusion, the present data indicate that administration of B. coagulans ATCC 7050 improved feed conversion ratio in broiler chickens, possibly via improving the balance of intestinal microflora.

This study investigated the effect of chromium picolinate supplementation on growth performance, carcass characteristics and lipid metabolism of growing-finishing pigs. Sixty Landrace ✕ Yorkshire ✕ Duroc (LYD) pigs with a mean initial body weight of 46·65 (s.e. 6·72) kg were randomly allocated into three groups with two replicates. They were supplemented with 0 , 200, or 400 μg/kg (ppb) chromium in the organic form of chromium picolinate for 90 days. Supplementation with chromium picolinate in the pigs’ ration improved their growth performance, enhanced average daily gain (P < 0·05), and increased their food consumption, especially in the 200 ppb group ( P > 0·05). Chromium picolinate supplementation also improved carcass characteristics, as the average back fat thickness was reduced and the loin-eye area was enhanced ( P < 0·05). The serum chromium concentration in the chromium picolinate supplemented groups was approximately twice that of the controls ( P < 0·05). Supplementation with chromium also markedly reduced serum total cholesterol, triacylglycerol (TG) and urea concentrations in the pig serum ( P < 0·05). Serum insulin was significantly decreased in the 400 ppb group, while serum glucose was decreased in the 200 ppb group ( P < 0·05). Very low density lipoprotein (VLDL) was reduced and low density lipoprotein (LDL) was increased in the chromium supplementation group. Meanwhile, the high density lipoprotein-cholesterol and VLDL-cholesterol were markedly increased, while LDL-cholesterol was significantly diminished ( P < 0·05) in the 200 ppb group. The adipocyte diameter and volume in the chromium-supplemented groups tended to be larger than in the control ( P = 0·07). In vitro studies indicated that incorporation of [u, 14C]glucose into total lipids (P < 0·05) was increased by chromium supplementation. However, there were no lipolysis differences among the groups (P > 0·05). The carcasses of the pigs that received the chromium supplemented ration contained less oleic acid (C18 : 1) and total unsaturated fatty acids (P < 0·05). On the other hand, the total saturated fatty acid content was higher than that of the controls (P < 0·05). Results in this study demonstrate that chromium picolinate supplementation in pigs has several beneficial effects.

This study was conducted to investigate the effects of various levels of nanoparticles chromium picolinate on performance, egg quality, minerals retention, and tissues accumulation of layer chickens. This study used 54 seventy-week old post-molt laying hens randomly allocated into 0 (control), 500 ppb (µg kg -1 ) Cr and 3000 ppb Cr groups for a 60-day experiment. The chromium was nanosize (80.8 ± 2.7 nm) chromium picolinate (NanoCrPic) and each treatment was undertaken with six replicates. In the meantime, a total of 18 birds (1 bird/replicate) were used for metabolic experimentation. The results of the experiment indicated that there were no significant effects on body weight, feed intake, feed efficiency, and egg production of layers. Supplemental NanoCrPic could significantly (p < 0.05) improve egg quality, or retention of chromium and zinc, but decrease shell ratio in the 60 th day eggs. The addition of NanoCrPic resulted in increased minerals accumulation in tissues such as Cr, Ca, and P concentration in the liver, Cr concentration in the yolk and Ca concentration in the eggshell. In conclusion, supplemental NanoCrPic improved Cr and Ca accumulation in the liver and egg, improved Zn and Mn retention in layer chickens.

1. This study investigated the effects of supplemental copper and chromium on the serum and egg traits of laying hens using 144 forty-five-week-old White Leghorn layers. The hens were randomly assigned into 9 groups to conduct this 3 copper (0, 125 and 250 mg/kg as copper sulphate) x 3 chromium (0, 800 and 1600 microg/kg as chromium picolinate) factorial trial. 2. Egg yolk cholesterol was significantly reduced by supplementary copper (Cu) and chromium (Cr) and there was an interaction between Cu and Cr supplementation. Egg production, egg weight, eggshell strength and eggshell thickness were not influenced by Cu or Cr supplementation. 3. Serum cholesterol concentration was decreased by Cu supplementation and very low-density lipoprotein (VLDL) was reduced markedly by both Cu and Cr. On the other hand, high-density lipoprotein (HDL) was significantly increased by Cu and Cr. Interaction occurred between Cu and Cr in the VLDL and HDL parameters. Supplmentary Cu also reduced VLDL-cholesterol (VLDL-C) and enhanced HDL-cholesterol (HDL-C), while supplemental Cr had a contrary effect on these two parameters. 4. If minimum egg cholesterol content is the criterion, this study suggests that 125 mg/kg of Cu together with 800 to 1600 microg/kg of Cr provide adequate supplementary concentrations for laying hens.

This study was conducted to investigate the effects of different levels nanoparticles of chromium picolinate (NanoCrPic) on the performance, immune responses, mineral retention, and tissues accumulation of chickens. A total of 180 broilers were randomly allocated into 0 (control), 500 ppb (µg kg -1 ) Cr and 3000 ppb Cr groups with 6 replicates (10 birds/pen) for a 35-day experiment, the Cr is nanoparticles of chromium picolinate (NanoCrPic). In addition, 36 birds were used for metabolic experimental investigation. The results of the experimentation indicated that there were no significant differences in average body weight gain between groups, but feed conversion ratio (FCR) in 3000 ppb group was better than control group during 1-21 days. The carcass yields slightly lower in 3000 ppb group than control (p<0.1). Retention ratio of Zn, Fe, Mn, Ca, and P were significantly (p<0.05) increased in the 500 ppb Cr group. The addition of NanoCrPic caused increased mineral concentrations, such as Cr, Ca and P in the subjects' livers. Furthermore, the addition of NanoCrPic significantly increased lymphocytes and decreased both heterophils and H/L ratio (p<0.05). The ND (Newcastle disease) antibody titer was not affected in the broilers. In conclusion, supplemental NanoCrPic improved the retention of Zn, Fe Ca, notably it increased the concentration of Cr and Ca in the liver, and also increased the number of lymphocytes in broiler chickens.

No abstract

1. The objective of this trial was to study the effects of chromium nicotinate (Cr) supplementation on the performance, carcase characteristics and blood constituents of 9 to 22 week-old male turkeys. 2. Fifty-four 8-week-old male turkeys weighing 2.9 +/- 0.28 kg were allocated at random into 9 groups with 3 dietary treatments and 3 replicates. The dietary treatment was different dietary concentrations of chromium in the basal diet, to provide 0 (control), 1 or 3 mg/kg. The feeding trial lasted for 14 weeks. 3. Results showed that 1 mg/kg chromium supplementation significantly improved weight gain and food intake at 9 to 18 weeks of age but did not significantly influence performance at 19 to 22 week of age. The breast and thigh muscle were significantly increased in birds receiving 1 mg/kg chromium supplementation but were decreased by 3 mg/kg of supplementation. 4. Dietary chromium supplementation did not significantly influence other serum constituents, including insulin, HDL, VLDL+LDL, HDL-C, VLDL-C+LDL-C, total protein, albumin, and gamma-globulin at 18 and 22 weeks of age. 5. The serum triacylglycerol (TG) and uric acid contents were significantly increased, while glycerol and alpha-globulin were significantly reduced by 3 mg/kg chromium supplementation. However, 1 mg/kg chromium supplementation significantly reduced serum cholesterol and glycerol at 18-weeks old. At 22 weeks of age, 1 mg/kg chromium supplementation significantly increased serum glucose and decreased the uric acid concentration whereas 3 mg/kg chromium supplementation significantly increased the creatinine concentration and decreased beta-globulin concentration.

No abstract